AdvaMedDx® Letter to VALID Sponsors
AdvaMedDx® wrote to affirm our commitment to make modernization of the regulatory framework for IVCTs a reality.
Diagnostics
Learn more about our Diagnostics work.
AdvaMedDx® Diagnostic Regulatory Reform Fact Sheet
Modernizing regulation of diagnostic tests is essential to improve patient care and support innovation.
AdvaMedDx® Media Message Points on the VALID Act
AdvaMedDx® has prepared a high-level FAQ document that addresses key questions you may receive about the bill.
AdvaMed®: VALID Act an “Important Step Toward the Long-Overdue Modernization” of Law Governing Diagnostic Tests
AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon re-introduction today in the House and Senate of the Verifying Accurate, Leading-edge…
Next Generation Dx Summit
Advancing Diagnostics Together: In-Person & Virtual offerings with complete coverage of the most timely and important issues for the diagnostics industry.
AdvaMedDx® VALID Act Webinar
The VALID Act marks a milestone in AdvaMedDx® efforts to secure a diagnostic-specific, risk-based and modernized for innovation, regulation of all diagnostic tests – LDTs and IVDs.
Join AdvaMed®DX
AdvaMedDx® members represent the world’s leading diagnostics manufacturers alongside the next generation of companies developing innovative diagnostic tests and technologies in the U.S. and abroad.
AdvaMed®DX Members
AdvaMedDx® members are medical technology firms that manufacture an in vitro diagnostic device or engage in research and development of such diagnostics.
AdvaMedDx®
AdvaMedDx® promotes innovation and expanded access to quality testing.
AdvaMed® Statement on Biden Administration Plan to Expand K-8 Testing
AdvaMed® released a response to the Biden administration’s announcement today of its plan to expand COVID-19 testing in our nation’s K-8 schools.